We are live on ! Find out more
CCP

Clough Capital Partners Portfolio holdings

AUM $1.23B
1-Year Est. Return 51.32%
This Fund
S&P 500
This Quarter Est. Return
-3.27%
1 Year Est. Return
+51.32%
3 Year Est. Return
+175.14%
5 Year Est. Return
+243.7%
10 Year Est. Return
+1,533.05%
AUM
$2.67B
AUM Growth
-$501M
Cap. Flow
-$362M
Cap. Flow %
-13.57%
Top 10 Hldgs %
22.99%
Holding
231
New
34
Increased
47
Reduced
85
Closed
50

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 24.47%
2 Financials 18.4%
3 Healthcare 17.11%
4 Energy 11.77%
5 Technology 8.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HAL icon
51
Halliburton
HAL
$29.7B
$21.2M 0.79%
327,900
-262,300
-44% -$18M
PGEN icon
52
Precigen
PGEN
$2.51B
$19.8M 0.74%
1,114,859
-22,078
-2% -$451K
RFMD
53
DELISTED
RF MICRO DEVICES INC
RFMD
$19.7M 0.74%
1,710,500
-72,200
-4% -$813K
CMPR icon
54
Cimpress
CMPR
$2.03B
$19.6M 0.73%
357,300
+110,300
+45% +$5.04M
FWONA icon
55
Liberty Media Series A
FWONA
$21.8B
$18.4M 0.69%
765,043
-1,472,962
-66% -$36.2M
EVTC icon
56
Evertec
EVTC
$1.69B
$17.5M 0.66%
784,484
-20,200
-3% -$462K
TVTY
57
DELISTED
Tivity Health, Inc. Common Stock
TVTY
$17M 0.64%
1,064,137
-347,000
-25% -$5.88M
NXPI icon
58
NXP Semiconductors
NXPI
$57.1B
$16.6M 0.62%
242,836
-309,800
-56% -$20.6M
CXO
59
DELISTED
CONCHO RESOURCES INC.
CXO
$16.5M 0.62%
131,483
-65,420
-33% -$8.95M
NBR icon
60
Nabors Industries
NBR
$1.36B
$16.2M 0.61%
14,272
+1,600
+13% +$2.13M
MDCO
61
DELISTED
Medicines Co
MDCO
$15.9M 0.59%
711,100
-101,100
-12% -$2.57M
GWPH
62
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$15.6M 0.58%
+192,600
New +$17M
GLD icon
63
SPDR Gold Trust
GLD
$145B
$15.5M 0.58%
133,790
EOG icon
64
EOG Resources
EOG
$80.6B
$15.2M 0.57%
153,444
+61,800
+67% +$6.72M
PTEN icon
65
Patterson-UTI
PTEN
$4.85B
$14.8M 0.56%
455,700
-141,300
-24% -$4.8M
ENDP
66
DELISTED
Endo International plc
ENDP
$14M 0.53%
205,300
-107,300
-34% -$7.07M
PRKS icon
67
United Parks & Resorts
PRKS
$1.63B
$13.9M 0.52%
+724,200
New +$17.3M
CLNY
68
DELISTED
Colony Capital, Inc.
CLNY
$13.5M 0.51%
603,600
-353,500
-37% -$7.96M
ALKS icon
69
Alkermes
ALKS
$7.72B
$13.2M 0.49%
307,100
-158,400
-34% -$7.1M
AVDL
70
DELISTED
Avadel Pharmaceuticals
AVDL
$12.7M 0.48%
887,650
+2,100
+0.2% +$30.2K
VLO icon
71
Valero Energy
VLO
$114B
$12.5M 0.47%
271,100
-140,800
-34% -$7.1M
CRI icon
72
Carter's
CRI
$1.07B
$12.5M 0.47%
+161,000
New +$12.4M
FITB
73
Fifth Third Bancorp
FITB
$49.6B
$12.4M 0.46%
+619,500
New +$12.7M
ZBH icon
74
Zimmer Biomet
ZBH
$18.8B
$12.3M 0.46%
+125,866
New +$12.4M
JAZZ icon
75
Jazz Pharmaceuticals
JAZZ
$15.6B
$12.2M 0.46%
76,191
-27,300
-26% -$4.2M

Similar funds

Clough Capital Partners's Q3 2014 Portfolio in Review

As of Q3 2014, Clough Capital Partners held 231 positions worth $2.67B, down 16% from $3.17B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Clough Capital Partners withdrew a net $362M in Q3 2014, closing 50 positions and reducing 85 holdings. Its most notable exit was Seagate, an estimated $58M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 24% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Clough Capital Partners opened a new position in Lam Research worth $44.3M.

  • Clough Capital Partners's largest Q3 2014 buy was Lam Research: 5,933,000 shares worth $44.3M.
  • Clough Capital Partners added most to Bank of America in Q3 2014, an estimated $33.5M increase.
  • Clough Capital Partners's biggest Q3 2014 reduction was Liberty Interactive Corporation Series A Liberty Ventures, cutting an estimated $37.1M.
  • Clough Capital Partners fully exited Seagate in Q3 2014, selling an estimated $58M.
  • Clough Capital Partners's ten largest holdings make up 23% of its $2.67B portfolio in Q3 2014.
  • Clough Capital Partners opened 34 new positions and closed 50 in Q3 2014.
  • Clough Capital Partners's portfolio value fell 16% quarter-over-quarter to $2.67B.

Based on Clough Capital Partners's 13F filing for Q3 2014, filed 14 Nov 2014.